07.16.14 -- FDA Approval Pushes Novartis Into 21st Century Vaccine Development
November 10 and 11, 2014 | Hyatt Regency, San Francisco, CA
• Who should attend? Pharma and biopharm executives who form and manage outsourcing partnerships.
• What's on the agenda? Educational sessions focused on best practices and industry leaders’ experiences and lessons learned to help you avoid costly mistakes.
Register today! Space is limited. Brought to you by Life Science Leader magazine, BayBio, and Outsourced Pharma.
FDA Approval Pushes Novartis Into 21st Century Vaccine Development By Trisha Gladd, Editor, Pharmaceutical Online and Bioresearch Online
In 2009, the world experienced a global threat in the form of H1N1. Despite a prompt response to the need for a vaccine in the United States, it was still not available until six months later, and not enough doses were even produced to cover all Americans. During the year-long battle with the deadly virus, the CDC estimates between 8,870 and 18,300 people died due to H1N1-related complications. In the world of influenza vaccine production using chicken eggs, the response experienced during the H1N1 outbreak is not uncommon. Is this the best our industry can do? Novartis says NO.
White Paper: Streamlining Particle Count Data Management By Paul Yates, Beckman Coulter Life Sciences
Pharmaceutical cleanrooms have gone through drastic changes in recent years as mergers, acquisitions, facility closures, drug patent cliffs, and other industry dynamics have forced manufacturing facilities to continually adapt to remain both competitive and compliant with U.S. FDA regulations.
Case Study: Process Train Containment In CMO Operations By ILC Dover
Handling HP/C compounds requires highly specialized facilities and controls. As part of Pharmatek’s overall corporate safety program, they chose to integrate ILC Dover Flexible Containment Solutions into their HP/C facilities.
October 27 to 29, 2014, The Ritz-Carlton, Laguna Niguel, CA
The #1 partnering event for the pharma and biotech industries.
Pharma/Biotechs: Get 25 percent off your registration with code BN14BIORSRCH. Learn more.
DASGIP Parallel Bioreactor Systems for microbiology offer the advantages of small working volumes and the full functionality of industrial bioreactors. The modular design of our systems allows flexible solutions for bioprocess development with aerobic and anaerobic bacteria as well as yeasts and fungi in laboratory scale. With our DASbox we also offer the most compact mini bioreactor system on the market.
A suitable cell culture medium for a cell-based vaccine manufacturing process is critical because it can significantly affect the overall efficiency and consistency of production, and it reduces contamination risks and potential inhibitors.
Pall Emflon FM filter cartridges are designed for cost-effective clarification of solvents used in the manufacture of antibiotics and other APIs. These pharmaceutical-grade filters contain a proprietary PTFE membrane and are compatible with a broad range of chemicals. They can also be used to ensure cleanliness of high-purity solvents.
Pure Sericin is applicable as a useful component of serum-free media. It is a protein derived from silkworms used for stimulation of cell proliferation, suppression of cell death, and cryopreservation of cells.